Targeted Therapy in Translational Cancer Research
In the last decade, emergent technologies have enhanced our understanding of genomic, transcriptional, proteomic, epigenetic, and immune mechanisms in carcinogenesis. This improved understanding has enabled the development of targeted cancer therapies and personalized management, and transformed conventional treatment paradigms. It has provided the framework for the discovery of new targets, for validation of novel agents, for combination therapies predicated upon scientific rationale, and for clinical trials that have already markedly improved the prognosis and outcome of patients with cancer.Over 37 chapters this volume of Translational Onc…
Mehr
CHF 122.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Markman, Maurie (Reihe Hrsg.) / Bast, Robert C. (Reihe Hrsg.) / Hawk, Ernest (Reihe Hrsg.) / Kurzrock, Razelle (Hrsg.) / Anderson, Kenneth C. (Hrsg.)
- ISBN: 978-1-118-46868-5
- EAN: 9781118468685
- Produktnummer: 19017293
- Verlag: Wiley-Blackwell
- Sprache: Englisch
- Erscheinungsjahr: 2015
- Seitenangabe: 400 S.
- Plattform: PDF
- Masse: 17'243 KB
Über den Autor
Apostolia-Maria Tsimberidou, MD PhDDepartment of Investigational Cancer TherapeuticsThe University of Texas MD Anderson Cancer CenterHouston, TX, USARazelle KurzrockCenter for Personalized Cancer Therapy, UC San Diego - Moores Cancer CenterLa Jolla, CA, USAKenneth C. Anderson MDLeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical SchoolBoston, MA, USA
2 weitere Werke von Apostolia-Maria (Hrsg.) Tsimberidou:
Bewertungen
Anmelden